{"id":30200,"date":"2025-01-18T09:09:03","date_gmt":"2025-01-18T14:09:03","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=30200"},"modified":"2025-01-18T09:09:03","modified_gmt":"2025-01-18T14:09:03","slug":"ipo-pipeline-venture-global-sets-terms-four-new-filings-emerge","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-venture-global-sets-terms-four-new-filings-emerge\/","title":{"rendered":"IPO Pipeline: Venture Global Sets Terms, Four New Filings Emerge"},"content":{"rendered":"<h3><strong>Venture Global Sets IPO Terms<\/strong><\/h3>\n<p>Venture Global, Inc., a rapidly growing leader in the liquefied natural gas (LNG) industry, has announced the terms for its initial public offering. The company has reshaped the LNG production landscape and is poised to make a significant splash on Wall Street.<\/p>\n<ul>\n<li><strong>Symbol:<\/strong> VG (NYSE)<\/li>\n<li><strong>Shares Offered:<\/strong> 50 million<\/li>\n<li><strong>Price Range:<\/strong> $40.00\u2013$46.00 per share<\/li>\n<li><strong>Expected Market Capitalization:<\/strong> $96.0 billion\u2013$110.4 billion<\/li>\n<li><strong>Trade Date:<\/strong> Friday, January 24, 2025<\/li>\n<li><strong>Underwriters:<\/strong> Goldman Sachs, J.P. Morgan, BofA Securities, and others<\/li>\n<li><strong>Co-Managers:<\/strong> National Bank of Canada Financial Markets, Raymond James, and others<\/li>\n<li><strong>Initial Prospectus Filed:<\/strong> December 20, 2024<\/li>\n<li><strong>Terms Finalized:<\/strong> January 13, 2025<\/li>\n<\/ul>\n<p>With an expected valuation exceeding $100 billion, Venture Global&#8217;s IPO is critical LNG to global markets during a period of growing energy demand.<\/p>\n<hr \/>\n<h3><strong>New IPO Filings<\/strong><\/h3>\n<p>Four additional companies have filed for IPOs, each aiming to capitalize on investor interest across various sectors, from biopharmaceuticals to building materials.<\/p>\n<h4><strong>Odyssey Therapeutics, Inc.<\/strong><\/h4>\n<ul>\n<li><strong>Symbol:<\/strong> ODTX (Nasdaq)<\/li>\n<li><strong>Description:<\/strong> A clinical-stage biopharmaceutical company targeting autoimmune and inflammatory diseases.<\/li>\n<li><strong>Shares\/Price Range:<\/strong> TBD<\/li>\n<li><strong>Underwriters:<\/strong> Goldman Sachs, Jefferies, TD Cowen<\/li>\n<li><strong>Co-Manager:<\/strong> Wedbush PacGrow<\/li>\n<li><strong>Prospectus Filed:<\/strong> January 18, 2025<\/li>\n<\/ul>\n<h4><strong>SailPoint, Inc.<\/strong><\/h4>\n<ul>\n<li><strong>Symbol:<\/strong> SAIL (Nasdaq)<\/li>\n<li><strong>Description:<\/strong> A provider of enterprise identity security solutions.<\/li>\n<li><strong>Shares\/Price Range:<\/strong> TBD<\/li>\n<li><strong>Underwriters:<\/strong> Morgan Stanley, Goldman Sachs<\/li>\n<li><strong>Prospectus Filed:<\/strong> January 18, 2025<\/li>\n<\/ul>\n<h4><strong>Sionna Therapeutics, Inc.<\/strong><\/h4>\n<ul>\n<li><strong>Symbol:<\/strong> SION (Nasdaq)<\/li>\n<li><strong>Description:<\/strong> Developing innovative treatments for cystic fibrosis by normalizing CFTR protein function.<\/li>\n<li><strong>Shares\/Price Range:<\/strong> TBD<\/li>\n<li><strong>Underwriters:<\/strong> Goldman Sachs, TD Cowen, Stifel, Guggenheim Securities<\/li>\n<li><strong>Prospectus Filed:<\/strong> January 18, 2025<\/li>\n<\/ul>\n<h4><strong>Titan America SA<\/strong><\/h4>\n<ul>\n<li><strong>Symbol:<\/strong> TTAM (NYSE)<\/li>\n<li><strong>Description:<\/strong> A leading supplier of heavy building materials along the U.S. Eastern Seaboard.<\/li>\n<li><strong>Shares\/Price Range:<\/strong> TBD<\/li>\n<li><strong>Underwriters:<\/strong> Citigroup, Goldman Sachs, BofA Securities, and others<\/li>\n<li><strong>Prospectus Filed:<\/strong> January 13, 2025<\/li>\n<\/ul>\n<hr \/>\n<h3><strong>IPO Market Outlook<\/strong><\/h3>\n<p>The flurry of activity signals growing momentum in the IPO market as companies from diverse sectors prepare to test investor appetite. Venture Global&#8217;s robust valuation and the variety of new entrants suggest that 2025 could be a banner year for public offerings.<\/p>\n<p>Investors will be closely watching Venture Global&#8217;s January 24 debut for indications of broader market sentiment as the IPO wave gains strength.<\/p>\n<h2>Terms Added<\/h2>\n<p><span style=\"font-weight: 400;\">Company: <\/span> <b>Venture Global, Inc.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: <\/span> <span style=\"font-weight: 400;\">VG (NYSE)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description: <\/span> <span style=\"font-weight: 400;\">Venture Global has fundamentally reshaped the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: <\/span> <span style=\"font-weight: 400;\">50 million<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: <\/span> <span style=\"font-weight: 400;\">40.00-$46.00<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Market Cap: <\/span> <span style=\"font-weight: 400;\">$96.0b-$110.4b<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 <\/span> <span style=\"font-weight: 400;\">Friday, 1\/24<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters:\u00a0 <\/span> <span style=\"font-weight: 400;\">Goldman Sachs, J.P. Morgan, BofA Securities, ING, RBC Capital, Scotiabank, Mizuho, Santander, SMBC Nikko, MUFG, BBVA, Loop Capital, Natixis, Deutsche Bank, Wells Fargo, Truist Securities<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Co-Manager(s): <\/span> <span style=\"font-weight: 400;\">National Bank of Canada Financial Markets, Raymond James, Regions Securities LLC, Guggenheim Securities, Tuohy Brothers<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectuses: <\/span> <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/2007855\/000119312524282957\/d146310ds1.htm\"><span style=\"font-weight: 400;\">Filed: 12-20-24<\/span><\/a><\/p>\n<p><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/2007855\/000119312525004922\/d146310ds1a.htm\"><span style=\"font-weight: 400;\">Terms Added: 1-13-25<\/span><\/a><\/p>\n<h2>New Filings<\/h2>\n<p><span style=\"font-weight: 400;\">Company: <\/span><b>Odyssey Therapeutics, Inc.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: ODTX (Nasdaq)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description: Odyssey is a clinical-stage biopharmaceutical company led by a team and board of drug hunters seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters: Goldman Sachs, Jefferies, TD Cowen<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Co-Manager: Wedbush PacGrow<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus: <\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1882782\/000119312525008362\/d818486ds1.htm\"><span style=\"font-weight: 400;\">Filed: 1-18-25<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Company: <\/span><b>SailPoint, Inc.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: SAIL (Nasdaq)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description: SailPoint delivers solutions to enable comprehensive identity security for the enterprise.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters: Morgan Stanley, Goldman Sachs<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus: <\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/2030781\/000119312525008417\/d885522ds1.htm\"><span style=\"font-weight: 400;\">Filed: 1-18-25<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Company: <\/span><b>Sionna Therapeutics, Inc.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: SION (Nasdaq)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description: They are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (\u201cCF\u201d) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (\u201cCFTR\u201d) protein to deliver clinically meaningful benefit to CF patients.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters: Goldman Sachs, TD Cowen, Stifel, Guggenheim Securities<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus: <\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/2036042\/000119312525008474\/d882384ds1.htm\"><span style=\"font-weight: 400;\">Filed: 1-18-25<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Company: <\/span><b>Titan America SA<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Symbol: TTAM (NYSE)<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Description: Titan America is a leading vertically integrated, multi-regional manufacturer and supplier of heavy building materials and services operating primarily on the Eastern Seaboard of the United States (the \u201cEastern Seaboard\u201d).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shares: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Price Range: TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trade Date:\u00a0 TBD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Underwriters: Citigroup, Goldman Sachs, BofA Securities, BNP PARIBAS, Jefferies, HSBC, SOCIETE GENERALE, Stifel<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus: <\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/2035304\/000119312525005308\/d833037df1.htm\"><span style=\"font-weight: 400;\">Filed: 1-13-25<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Venture Global Sets IPO Terms Venture Global, Inc., a rapidly growing leader in the liquefied natural gas (LNG) industry, has announced the terms for its initial public offering. The company has reshaped the LNG production landscape and is poised to make a significant splash on Wall Street. Symbol: VG (NYSE) Shares Offered: 50 million Price[&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-30200","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/30200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=30200"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/30200\/revisions"}],"predecessor-version":[{"id":30201,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/30200\/revisions\/30201"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=30200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=30200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=30200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}